Phase 4 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are having a first-time shoulder replacement surgery on one shoulder (either a standard or reverse type of artificial shoulder joint)
- People with a body mass index (a measure of body weight relative to height) between 18.5 and 35
- People who are able to give written consent and are able to follow all the steps required by the study
- People who have signed a consent form agreeing to take part
Who may not be able to join:
- People for whom steroid medications are medically unsuitable
- People having a repeat (revision) shoulder replacement or one needed because of an injury
- People who have used steroid or immune-suppressing medications in the 30 days before their operation
- Women who are pregnant or breastfeeding
- People with serious additional health conditions classified as very high medical risk (confirm with trial site)
- People with diabetes that is not well controlled
- People for whom anti-inflammatory pain medications (such as ibuprofen) are medically unsuitable
- People with long-term conditions affecting the whole body, such as immune deficiency, lupus, gout, or rheumatoid arthritis
- People with known or suspected issues with following medical instructions, or with drug or alcohol dependency
- People who may have difficulty following study procedures due to language barriers, psychological conditions, or dementia
- People who have taken part in another clinical trial involving an investigational medication in the 30 days before or during this study
- People who have previously been enrolled in this same study
- The researchers running the trial, their family members, their employees, or anyone who depends on them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christian Candrian, Prof.Dr.med, EOC
Phone: +41 (0) 91 811 61 23
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
mean post-operative daily pain at rest
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.